Compare Revvity Inc (RVTY) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Verizon Communications Inc — how do they compare? Revvity Inc trades at $154.18 (market cap $16.98B), while Verizon Communications Inc trades at $41.65 (market cap $192.57B). The key difference: Verizon Communications Inc is far larger — about 11.3× Revvity Inc's market cap, and Verizon Communications Inc pays the higher dividend (6.11%). Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 12 Days and Verizon Communications Inc for 109 Days on average.
| RVTY | VZ | |
|---|---|---|
Market Cap | $16.98B | $192.57B |
Volume | 1,456,900 | 20,940,094 |
Sector | Health | Media |
52-Week High | $157.36 | $51.45 |
52-Week Low | $82.26 | $38.40 |
Typical Hold Time | 12 Days | 109 Days |
Enterprise Value | $19.30B | $379.28B |
Dividend Yield | 0.18% | 6.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $152.16, down 0.94% on the day, but maintains a bullish technical trend with strong moving average signals and support near $149. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue remains stable around $2.9 billion, though net income margins have softened slightly. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal, to bolster its life sciences portfolio.
The outlook is supported by analyst optimism with a 51.72% buy rating and a consensus price target of $132.13, though the current price trades above this target. Key risks include premium valuation metrics, margin pressures, and exposure to macroeconomic headwinds. The stock's proximity to its 52-week high suggests momentum but warrants caution given rich multiples.
Verizon (VZ) trades at $46.35, up 1.27% today, with a bearish technical signal despite recent earnings beats. The stock shows stable revenue around $138B annually with strong cash flow generation of $37.1B from operations in 2025. Valuation metrics appear reasonable with P/E of 12.07 and EV/EBITDA of 7.9, while the company maintains a solid dividend yield supported by consistent cash flows.
Outlook remains stable with moderate growth prospects amid competitive telecom landscape. Investment appeal centers on dividend reliability and defensive positioning, though technical weakness and modest revenue growth present near-term challenges. Risks include intense competition and capital expenditure requirements for network expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
